Equities analysts expect Xylem Inc (NYSE:XYL) to post earnings of $0.78 per share for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Xylem’s earnings, with the lowest EPS estimate coming in at $0.76 and the highest estimate coming in at $0.80. Xylem reported earnings per share of $0.65 in the same quarter last year, which indicates a positive year over year growth rate of 20%. The company is expected to announce its next earnings report on Tuesday, October 30th.

According to Zacks, analysts expect that Xylem will report full year earnings of $2.91 per share for the current fiscal year, with EPS estimates ranging from $2.87 to $2.95. For the next fiscal year, analysts forecast that the business will report earnings of $3.43 per share, with EPS estimates ranging from $3.35 to $3.56. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that follow Xylem.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.02. Xylem had a return on equity of 19.04% and a net margin of 7.39%. The company had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.28 billion. During the same period in the previous year, the business earned $0.59 earnings per share. Xylem’s quarterly revenue was up 13.1% compared to the same quarter last year.

Several equities analysts have recently commented on the company. Raymond James assumed coverage on Xylem in a research report on Wednesday, September 5th. They issued an “outperform” rating and a $90.00 price objective on the stock. BMO Capital Markets boosted their price objective on Xylem from $83.00 to $84.00 and gave the company an “outperform” rating in a research report on Wednesday, August 1st. Robert W. Baird restated a “hold” rating and issued a $80.00 price objective on shares of Xylem in a research report on Wednesday, August 1st. Stifel Nicolaus boosted their price objective on Xylem from $75.00 to $80.00 and gave the company a “hold” rating in a research report on Wednesday, August 1st. Finally, Zacks Investment Research downgraded Xylem from a “hold” rating to a “sell” rating in a research report on Monday, July 16th. Four investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $82.82.

In related news, insider Paul A. Stellato sold 1,500 shares of the business’s stock in a transaction dated Wednesday, September 19th. The stock was sold at an average price of $82.00, for a total value of $123,000.00. Following the sale, the insider now directly owns 12,796 shares in the company, valued at $1,049,272. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Colin R. Sabol sold 17,161 shares of the business’s stock in a transaction dated Monday, September 17th. The stock was sold at an average price of $81.37, for a total value of $1,396,390.57. Following the completion of the sale, the insider now owns 41,988 shares in the company, valued at $3,416,563.56. The disclosure for this sale can be found here. Insiders sold 49,284 shares of company stock worth $3,839,982 over the last quarter. 0.81% of the stock is owned by company insiders.

Several large investors have recently bought and sold shares of XYL. Flagship Harbor Advisors LLC bought a new stake in Xylem during the second quarter worth approximately $106,000. Smithfield Trust Co. increased its stake in Xylem by 1,690.0% during the second quarter. Smithfield Trust Co. now owns 1,611 shares of the industrial products company’s stock worth $108,000 after acquiring an additional 1,521 shares during the last quarter. Fort L.P. bought a new stake in Xylem during the second quarter worth approximately $118,000. Stelac Advisory Services LLC bought a new stake in Xylem during the second quarter worth approximately $125,000. Finally, Piedmont Investment Advisors LLC bought a new stake in Xylem during the second quarter worth approximately $139,000. Institutional investors own 85.81% of the company’s stock.

Shares of Xylem stock traded up $0.17 during trading hours on Thursday, hitting $80.23. The company’s stock had a trading volume of 28,379 shares, compared to its average volume of 835,634. Xylem has a 12-month low of $62.19 and a 12-month high of $82.44. The company has a market capitalization of $14.59 billion, a price-to-earnings ratio of 33.34, a PEG ratio of 1.55 and a beta of 1.26. The company has a quick ratio of 1.02, a current ratio of 1.43 and a debt-to-equity ratio of 0.86.

The company also recently announced a quarterly dividend, which was paid on Thursday, September 20th. Investors of record on Thursday, August 30th were given a $0.21 dividend. The ex-dividend date of this dividend was Wednesday, August 29th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.05%. Xylem’s dividend payout ratio is currently 35.00%.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Recommended Story: What are the reasons investors use put options?

Get a free copy of the Zacks research report on Xylem (XYL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.